Company intelligence / Profile preview

Moroxite

Ownership: Private
Development stage: Other

Overview

Moroxite’s technology has demonstrated enhanced immediate mechanical anchorage of hip fracture fixation devices in osteoporotic bone both in laboratory and early clinical settings. A published study showed new bone formation and improved implant stability when using their hydroxyapatite/calcium sulphate ceramic with subsequent bisphosphonate administration. The company’s approach is being validated in ongoing clinical trials.

Therapeutic areas: EndocrinologyOther
Modalities: DeviceBiologicSmall molecule
Industry: Implantable Medical Devices

Partnerships

Collaborations with academic research groups including Lund University TERM group and international partners from Sweden, Lithuania, Germany, ChinaNo major pharma partnerships disclosed

Beyond the preview

Go deeper on Moroxite.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Moroxite.

Explore the full profile